SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-23-000076
Filing Date
2023-05-09
Accepted
2023-05-09 16:04:58
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20230331.htm   iXBRL 10-Q 912909
2 DRI HEALTHCARE PURCHASE AND SALE AGREEMENT exhibit101driredactedagree.htm EX-10.1 398123
3 EX-31.1 exhibit31-1q12023.htm EX-31.1 9165
4 EX-31.2 exhibit31-2q12023.htm EX-31.2 9167
5 EX-32.1 exhibit32-1q12023.htm EX-32.1 4095
6 EX-32.2 exhibit32-2q12023.htm EX-32.2 3930
  Complete submission text file 0001125345-23-000076.txt   5334941

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20230331.xsd EX-101.SCH 41512
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20230331_cal.xml EX-101.CAL 44085
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20230331_def.xml EX-101.DEF 204753
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20230331_lab.xml EX-101.LAB 469735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20230331_pre.xml EX-101.PRE 331473
51 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20230331_htm.xml XML 683989
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 23901869
SIC: 2834 Pharmaceutical Preparations